An overlapping binding site in the CYP7A1 promoter allows activation of FXR to override the stimulation by LXRalpha
- PMID: 17690173
- DOI: 10.1152/ajpgi.00209.2007
An overlapping binding site in the CYP7A1 promoter allows activation of FXR to override the stimulation by LXRalpha
Abstract
The aim of this study was to explore why in rabbits activation of farnesoid X receptor (FXR) is dominant over activated liver X receptor-alpha (LXRalpha) in the regulation of CYP7A1. We cloned the rabbit CYP7A1 promoter and found a fetoprotein transcription factor (FTF) binding element embedded within the LXRalpha binding site (LXRE). Gel shift assays demonstrated that FTF competes with LXRalpha for binding to LXRE. Short heterodimer partner (SHP) enhances the competitive ability of FTF. Studies in HepG2 cells showed that SHP combined with FTF had more powerful effect to offset the stimulation of CYP7A1 by LXRalpha. Gel shift and chromatin immunoprecipitation assays demonstrated that SHP with FTF diminished LXRalpha binding to the CYP7A1 promoter. In vivo studies in rabbits fed cholesterol for 10 days showed that hepatic expression of SHP but not FTF rose and LXRalpha-bound LXRE decreased. We propose that the SHP/FTF heterodimer occupies LXRE via the embedded FTF binding element and blocks LXRalpha from recruiting to LXRE. Therefore, activation of FXR, which upregulates SHP expression, will eliminate the stimulatory effect of LXRalpha on the CYP7A1 promoter because increased levels of SHP combined with FTF diminish the recruitment of LXRalpha to CYP7A1 promoter.
Similar articles
-
The stimulatory effect of LXRalpha is blocked by SHP despite the presence of a LXRalpha binding site in the rabbit CYP7A1 promoter.J Lipid Res. 2006 May;47(5):997-1004. doi: 10.1194/jlr.M500449-JLR200. Epub 2006 Feb 17. J Lipid Res. 2006. PMID: 16489206
-
Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids.J Lipid Res. 2001 Sep;42(9):1402-12. J Lipid Res. 2001. PMID: 11518759
-
Dietary cholesterol stimulates CYP7A1 in rats because farnesoid X receptor is not activated.Am J Physiol Gastrointest Liver Physiol. 2004 May;286(5):G730-5. doi: 10.1152/ajpgi.00397.2003. Epub 2003 Dec 18. Am J Physiol Gastrointest Liver Physiol. 2004. PMID: 14684380
-
Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP.J Lipid Res. 2002 Apr;43(4):533-43. J Lipid Res. 2002. PMID: 11907135 Review.
-
Nuclear orphan receptors control cholesterol catabolism.Cell. 1999 May 28;97(5):539-42. doi: 10.1016/s0092-8674(00)80763-1. Cell. 1999. PMID: 10367881 Review. No abstract available.
Cited by
-
Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis.Liver Res. 2020 Jun;4(2):47-63. doi: 10.1016/j.livres.2020.05.001. Epub 2020 Jun 3. Liver Res. 2020. PMID: 34290896 Free PMC article.
-
FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels.J Lipid Res. 2013 Oct;54(10):2606-14. doi: 10.1194/jlr.M034827. Epub 2013 Jul 12. J Lipid Res. 2013. PMID: 23852734 Free PMC article.
-
Sustained upregulation of sodium taurocholate cotransporting polypeptide and bile salt export pump and downregulation of cholesterol 7α-hydroxylase in the liver of patients with end-stage primary biliary cirrhosis.Med Mol Morphol. 2010 Sep;43(3):134-8. doi: 10.1007/s00795-009-0480-9. Epub 2010 Sep 21. Med Mol Morphol. 2010. PMID: 20857261
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources